NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: Role in the NK cell-mediated negative regulation of T cell responses

Frontiers in Immunology

Volumn 3, Issue JAN, 2012, Pages

  Zingoni, Alessandra ^a   Ardolino, Michele ^a,c   Santoni, Angela ^a,b   Cerboni, Cristina ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell proliferation; DNA damage response; DNAM 1 ligands; NK T cell cross talk; NKG2D ligands

Indexed keywords

EID: 84874232157     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00408     Document Type: Short Survey

References (89)

1. Andoniou, C. E., van Dommelen, S. L., Voigt, V., Andrews, D. M., Brizard, G., Asselin-Paturel, C., et al. (2005). Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat. Immunol. 10, 1011-1019.
2. Andoniu, C. E., Coudert, J. D., and Degli Esposti, M. A. (2008). Killers and beyond: NK-cell-mediated control of immune response. Eur. J. Immunol. 38, 2938-2942.
3. Andresen, L., Hansen, K. A., Jensen, H., Pedersen, S. F., Stougaard, P., Hansen, H. R., et al. (2009). Propi-onic acid secreted from propionibac-teria induces NKG2D ligand expression on human-activated T lymphocytes and cancer cells. J. Immunol. 183, 897-906.
4. Ardolino, M., Zingoni, A., Cerboni, C., Cecere, F., Soriani, A., Iannitto, M. L., et al. (2011). DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction. Blood 117, 4778-4786.
5. Bottino, C., Castriconi, R., Pende, D., Rivera, P., Nanni, M., Carnemolla, B., et al. (2003). Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J. Exp. Med. 198, 557-567.
6. Cella, M., Presti, R., Vermi, W., Lavender, K., Turnbull, E., Ochsenbauer-Jambor, C., et al. (2010). Loss of DNAM-1 contributes to CD8+ T-cell exhaustion in chronic HIV-1 infection. Eur. J. Immunol. 40, 949-954.
7. Cerboni, C., Zingoni, A., Cippitelli, M., Piccoli, M., Frati, L., and Santoni, A. (2007a). Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK-cell lysis. Blood 110, 606-615.
8. Cerboni, C., Neri, F., Casartelli, N., Zingoni, A., Cosman, D., Rossi, P., et al. (2007b). Human immunodeficiency virus 1 Nef protein downmod-ulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity. J. Gen. Virol. 88, 242-250.
9. Cerboni, C., Ardolino, M., Santoni, A., and Zingoni, A. (2009). Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells. Blood 113, 2955-2964.
10. Chen, H. T., Bhandoola, A., Difilippan-tonio, M. J., Zhu, J., Brown, M. J., Tai, X., et al. (2000). Response to RAG-mediated V(D)J cleavage by NBS1 and γ-H2AX. Science 290, 1962-1965.
11. Correa, I., Corral, L., and Raulet, D. H. (1994). Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells. Eur. J. Immunol. 24, 1323-1331.
12. Eagle, R. A., and Trowsdale, J. (2007). Promiscuity and the single receptor: NKG2D. Nat. Rev. Immunol. 7, 737-744.
13. Eissmann, P., Evans, J. H., Mehrabi, M., Rose, E. L., Nedvetzki, S., and Davis, D. M. (2010). Multiple mechanisms downstream of TLR-4 stimulation allow expression of NKG2D ligands to facilitate macrophage/NK cell crosstalk. J. Immunol. 184, 6901-6909.
14. Erickson, B. M., Thompson, N. L., and Hixson, D. C. (2006). Tightly regulated induction of the adhesion molecule necl-5/CD155 during rat liver regeneration and acute liver injury. Hepatology 43, 325-334.
15. Flodström-Tullberg, M., Bryceson, Y. T., Shi, F. D., Höglund, P., and Ljung-gren, H. G. (2009). Natural killer cells in human autoimmunity. Curr. Opin. Immunol. 21, 634-640.
16. Fogli, M., Mavilio, D., Brunetta, E., Varchetta, S., Ata, K., Roby, G., et al. (2008). Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals. PLoS Pathog. 4:7. doi: 10.1371/journal.ppat.1000101.
17. Fort, M. M., Leach, M. W., and Rennick, D. M. (1998). A role for NK cells as regulators of CD4+ T cells in a transfer model of colitis. J. Immunol. 161, 3256-3261.
18. French, A. R., and Yokoyama, W. M. (2004). Natural killer cells and autoimmunity. Arthritis Res. Ther. 6, 8-14.
19. Fukao, T., Kaneko, H., Birrell, G., Tashita, H., Yoshida, T., Cross, S., et al. (1999). ATM is upregulated during the mitogenic response in peripheral blood mononuclear cells. Blood 94, 1998-2006.
20. Galazka, G., Jurewicz, A., Orlowski, W., Stasiolek, M., Brosnan, C. F., Rainem C. S., et al. (2007). EAE tolerance induction with Hsp70-peptide complexes depends on H60 and NKG2D activity. J. Immunol. 179, 4503-4512.
21. Gasser, S., Orsulic, S., Brown, E. J., and Raulet, D. H. (2005). The DNA damage pathway regulates innate immune system ligands for the NKG2D receptor. Nature 436, 1186-1190.
22. Groh, V., Bruhl, A., El-Gabalawy, H., Nelson, J. L., and Spies, T. (2003). Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc. Natl. Acad. Sci. U.S.A. 100, 9452-9457.
23. Hamerman, J. A., Ogasawara, K., and Lanier, L. L. (2004). Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. J. Immunol. 172, 2001-2005.
24. He, J., Choe, S., Walker, R., Di Marzio, P., Morgan, D. O., and Landau, N. R. (1995). Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69, 6705-6711.
25. Jinushi, M., Takehara, T., Kanto, T., Tatsumi, T., Groh, V., Spies, T., et al. (2003a). Critical role of MHC class I-related chainA and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection. J. Immunol. 170, 1249-1256.
26. Jinushi, M., Takehara, T., Tatsumi, T., Kanto, T., Groh, V., Spies, T., et al. (2003b). Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection. J. Immunol. 171, 5423-5429.
27. Jowett, J. B., Planelles, V., Poon, B., Shah, N. P., Chen, M. L., and Chen, I. S. (1995). The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 M phase of the cell cycle. J. Virol. 69, 6304-6313.
28. Kloss, M., Decker, P., Baltz, K. M., Baessler, T., Jung, G., Rammensee, H. G., et al. (2008). Interaction of mono-cytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA. J. Immunol. 181, 6711-6719.
29. Lang, P. A., Lang, K. S., Xu, H. C., Grusdat, M., Parish, I. A., Recher, M., et al. (2012). Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. Proc. Natl. Acad. Sci. U.S.A. 109, 1210-1215.
30. Lanier, L. L. (2008). Evolutionary struggles between NK cells and viruses. Nat. Rev. Immunol. 8, 259-268.
31. Leavenworth, J. W., Wang, X., Wenan-der, C. S., Spee, P., and Cantor, H. (2011). Mobilization of natural killer cells inhibits development of collagen-induced arthritis. Proc. Natl. Acad. Sci. U.S.A. 108, 14584-14589.
32. Lee, I. F., Qin, H., Trudeau, J., Dutz, J., and Tan, R. (2004). Regulation of autoimmune diabetes by complete Freund's adjuvant is mediated by NK cells. J. Immunol. 172, 937-942.
33. Li, J., Rabinovich, B. A., Hurren, R., Cos-man, D., and Miller, R. G. (2005). Survival versus neglect: redefining thymocyte subsets based on expression of NKG2D ligand(s) and MHC class I. Eur. J. Immunol. 35, 439-448.
34. Lu, L., Ikizawa, K., Hu, D., Wer-neck, M. B., Wucherpfennig, K. W., and Cantor, H. (2007). Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. Immunity 26, 593-604.
35. Lünemann, A., Lünemann, J. D., Roberts, S., Messmer, B., Barreira da Silva, R., Raine, C. S., et al. (2008). Human NK cells kill resting but not activated microglia via NKG2D-and NKp46-mediated recognition. J. Immunol. 181, 6170-6177.
36. Lünemann, A., Lünemann, J. D., and Münz, C. (2009). Regulatory NK-cell functions in inflammation and autoimmunity. Mol. Med. 15, 352-358.
37. Maasho, K., Opoku-Anane, J., Marusina, A. I., Coligan, J. E., and Borrego, F. (2005). NKG2D is a costimulatory receptor for human naive CD8+ T cells. J. Immunol. 174, 4480-4484.
38. Matloubian, M., Suresh, M., Glass, A., Galvan, M., Chow, K., Whitmire, J. K., et al. (1999). A role for perforin in downregulating T-cell responses during chronic viral infection. J. Virol. 73, 2527-2536.
39. Matsumoto, Y., Kohyama, K., Aikawa, Y., Shin, T., Kawazoe, Y., Suzuki, Y., et al. (1998). Role of natural killer cells and TCR gamma delta T cells in acute autoimmune encephalomyelitis. Eur. J. Immunol. 28, 1681-1688.
40. Matusali, G., Potestà, M., Santoni, A., Cerboni, C., and Doria, M. (2012). The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR. J. Virol. 86, 4496-4504.
41. Molinero, L. L., Fuertes, M. B., Rabi-novich, G. A., Fainboim, L., and Zwirner, N. W. (2002). Activation-induced expression of MICA on T lymphocytes involves engagement of CD3 and CD28. J. Leukoc. Biol. 71, 791-797.
42. Molinero, L. L., Fuertes, M. B., Girart, M. V., Fainboim, L., Rabinovich, G. A., Costas, M. A., et al. (2004). NFκB regulates expression of the MHC class I-related chain A gene in activated T lymphocytes. J. Immunol. 173, 5583-5590.
43. Nedvetzki, S., Sowinski, S., Eagle, R. A., Harris, J., Vély, F., Pende, D., et al. (2007). Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses. Blood 109, 3776-3785.
44. Nielsen, N., Ødum, N., Ursø, B., Lanier, L. L., and Spee, P. (2012). Cytotox-icity of CD56bright NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A. PLoS ONE 7:e31959. doi: 10.1371/journal.pone.0031959
45. Nilsson, N., Bremell, T., Tarkowski, A., and Carlsten, H. (1999). Protective role of NK1.1+ cells in experimental Staphylococcus aureus arthritis. Clin. Exp. Immunol. 117, 63-69.
46. Nolte-'t Hoen, E. N. M., Almeida, C. R., Cohen, N. R., Nedvetzki, S., Yarwood, H., et al. (2007). Increased surveillance of cells in mitosis by human NK cells suggests a novel strategy for limiting tumor growth and viral replication. Blood 109, 670-673.
47. Norman, J. M., Mashiba, M., McNamara, L. A., Onafuwa-Nuga, A., Chiari-Fort, E., Shen, W., et al. (2011). The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells. Nat. Immunol. 12, 975-983.
48. Noval Rivas, M., Hazzan, M., Weatherly, K., Gaudray, F., Salmon, I., and Braun, M. Y. (2010). NK cell regulation of CD4 T cell-mediated graft-versus-host disease. J. Immunol. 184, 6790-6798.
49. Nowbakht, P., Ionescu, M. C., Rohner, A., Kalberer, C. P., Rossy, E., Mori, L., et al. (2005). Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias. Blood 105, 3615-3622.
50. Ogasawara, K., Benjamin, J., Takaki, R., Phillips, J. H., and Lanier, L. L. (2005). Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts. Nat. Immunol. 6, 938-945.
51. Olson, J. A., Zeiser, R., Beilhack, A., Goldman, J. J., and Negrin, R. S. (2009). Tissue-specific homing and expansion of donor NK cells in allo-geneic bone marrow transplantation. J. Immunol. 183, 3219-3228.
52. Olson, J. A., Leveson-Gowere, D. B., Baker, J., Beilhack, A., and Negrin, R. S. (2010). NK cells mediate reduction of GVHD by inhibiting activated, aloreactive T cells while retaining GVT effects. Blood 115, 4293-4301.
53. Oricchio, E., Saladino, C., Iacovelli, S., Soddu, S., and Cundari, E. (2006). ATM is activated by default in mitosis, localizes at centrosomes and monitors mitotic spindle integrity. Cell Cycle 5, 88-92.
54. Pende, D., Castriconi, R., Romagnani, P., Spaggiari, G. M., Marcenaro, S., Dondero, A., et al. (2006). Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction. Blood 107, 2030-2036.
55. Pham, T. N., Richard, J., Gerard, F. C., Power, C., and Cohen, E. A. (2011). Modulation of NKG2D-mediated cytotoxic functions of natural killer cells by viral protein R from HIV-1 primary isolates. J. Virol. 85, 12254-12261.
56. Poggi, A., Prevosto, C., Massaro, A. M., Negrini, S., Urbani, S., Pierri, I., et al. (2005). Interaction between human NK cells and bone marrow stromal cells induces NK cell triggering: role of NKp30 and NKG2D receptors. J. Immunol. 175, 6352-6360.
57. Qiao, Y., Liu, B., and Li, Z. (2008). Activation of NK cells by extracellular heat shock protein 70 through induction of NKG2D ligands on dendritic cells. Cancer Immun. 8, 12-20.
58. Rabinovich, B. A., Li, J., Shannon, J., Hurren, R., Chalupny, J., Cosman, D., et al. (2003). Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells. J. Immunol. 170, 3572-3576.
59. Re, F., Braaten, D., Frankem, E. K., and Luban, J. (1995). Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J. Virol. 69, 6859-6864.
60. Richard, J., Sindhu, S., Pham, T. N., Belzile, J. P., and Cohen, E. A. (2010). HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing. Blood 115, 1354-1363.
61. Roshal, M., Kim, B., Zhu, Y., Nghiem, P., and Planelles, V. (2003). Activation of the ATR-mediated DNA damage response by the HIV-1 viral protein R. J. Biol. Chem. 278, 25879-25886.
62. Rossini, G., Cerboni, C., Santoni, A., Landini, M. P., Landolfo, S., Gatti, D., et al. (2012). Interplay between human cytomegalovirus and intrinsic/innate host responses: a complex bidirectional relationship. Mediat. Inflamm. 2012, 1-16.
63. Roy, S., Barnes, P. F., Garg, A., Wu, S., Cosman, D., and Vankayalapati, R. (2008). NKcells lyseT regulatorycells that expand in response to an intra-cellular pathogen. J. Immunol. 180, 1729-1736.
64. Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., et al. (2002). Effectiveness of donor natural killer cell alloreac-tivity in mismatched hematopoietic transplants. Science 295, 2097-2100.
65. Schott, E., Bonasio, R., and Ploegh, H. L. (2003). Elimination of in vivo developing T cells by natural killer cells. J. Exp. Med. 198, 1213-1224.
66. Schrama, D., Terheyden, P., Otto, K., Kämmerer, U., Bröcker, E. B., Lühder, F., et al. (2006). Expression of the NKG2D ligand UL16 binding protein-1 (ULBP-1) on dendritic cells. Eur. J. Immunol. 36, 65-72.
67. Schulz, U., Kreutz, M., Multhoff, G., Stoelcker, B., Köhler, M., Andreesen, R., et al. (2010). Interleukin-10 promotes NK cell killing of autologous macrophages by stimulating expression of NKG2D ligands. Scand. J. Immunol. 72, 319-331.
68. Shi, F. D., Takeda, K., Akira, S., Sarvet-nick, N., and Ljunggren, H. G. (2000). IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-gamma by NK cells. J. Immunol. 165, 3099-3104.
69. Shi, F. D., and Van Kaer, L. (2006). Reciprocal regulation between natural killer cells and autoreactive T cells. Nat. Rev. Immunol. 6, 751-760.
70. Shibuya, A., Campbell, D., Hannum, C., Yssel, H., Franz-Bacon, K., McClana-han, T., etal. (1996). DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 4, 573-581.
71. Sivori, S., Carlomagno, S., Falco, M., Romeo, E., Moretta, L., and Moretta, A. (2011). Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in hap-loidentical HSCT. Blood 117, 4284-4292.
72. Skov, S., Pedersen, M. T., Andresen, L., Straten, P. T., Woetmann, A., and Odum, N. (2005). Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B. Cancer Res. 65, 11136-11145.
73. Smeltz, R. B., Wauben, M. H., Wolf, N. A., and Swanborg, R. H. (1999). Critical requirement for aspartic acid at position 82 of myelin basic protein 73-86 for recruitment of V beta 8.2+ T cells and encephalitogenicity in the Lewis rat. J. Immunol. 162, 829-836.
74. Spaggiari, G. M., Capobianco, A., Bec-chetti, S., Mingari, M. C., and Moretta, L. (2006). Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 107, 1484-1490.
75. Soriani, A., Zingoni, A., Cerboni, C., Iannitto, M. L., Ricciardi, M. R., Di Gialleonardo, V., et al. (2009). ATM-ATR dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood 113, 3503-3511.
76. Stanietsky, N., Simic, H., Arapovic, J., Toporik, A., Levy, O., Novik, A., et al. (2009). The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. Proc. Natl. Acad. Sci. U.S.A. 106, 17858-17863.
77. Su, H. C., Nguyen, K. B., Salazar-Mather, T. P., Ruzek, M. C., Dalod, M. Y., and Biron, C. A. (2001). NK cell functions restrain T cell responses during viral infections. Eur. J. Immunol. 31, 3048-3055.
78. Tahara-Hanaoka, S., Shibuya, K., Onoda, Y., Zhang, H., Yamazaki, S., Miyamoto, A., et al. (2004). Functional characterization of DNAM-1 (CD226) interaction with its lig-ands PVR (CD155) and nectin-2 (PRR-2/CD112). Int. Immunol. 16, 533-538.
79. Tahara-Hanaoka, S., Shibuya, K., Kai, H., Miyamoto, A., Morikawa, Y., Ohkochi, N., et al. (2006). Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor. Blood 107, 1491-1496.
80. Tanaka, T., Kajstura, M., Halicka, H. D., Traganos, F., and Darzynkiewicz, Z. (2007). Constitutive histone H2AX phosphorylation and ATM activation are strongly amplified during mito-genic stimulation of lymphocytes. Cell Prolif. 40, 1-13.
81. Van Belle, T. L., and von Herrath, M. G. (2009). The role of the activating receptor NKG2D in autoimmunity. Mol. Immunol. 47, 8-11.
82. Venkataraman, G. M., Suciu, D., Groh, V., Boss, J. M., and Spies, T. (2007). Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D. J. Immunol. 178, 961-969.
83. Waggoner, S. N., Cornberg, M., Selin, L. K., and Welsh, R. M. (2011). Natural killer cells act as rheostats modulating antiviral T cells. Nature 481, 394-398.
84. Ward, J., Bonaparte, M., Sacks, J., Guterman, J., Fogli, M., Mavilio, D., et al. (2007). HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts. Blood 110, 1207-1214.
85. Ward, J., Davis, Z., DeHart, J., Zimmerman, E., Bosque, A., Brunetta, E., et al. (2009). HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response. PLoS Pathog. 5:10. doi: 10.1371/journal.ppat.1000613
86. Xu, W., Fazekas, G., Hara, H., and Tabira, T. (2005). Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 163, 24-30.
87. Yamaji, O., Nagaishi, T., Totsuka, T., Onizawa, M., Suzuki, M., Tsuge, N., et al. (2012). The development of colitogenic CD4(+) T cells is regulated by IL-7 in collaboration with NK cell function in a murine model of colitis. J. Immunol. 188, 2524-2536.
88. Yang, C., and Kastan, M. (2000). Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. Nat. Cell Biol. 2, 893-898.
89. Zhang, B., Yamamura, T., Kondo, T., Fujiwara, M., and Tabira, T. (1997). Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 186, 1677-1687.